VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO:MEDI) (OTC:KONEF) (FRA:SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research is pleased to announce that Dr. Corey Hilmas MD, PhD, a member of the Company’s Medical Advisory Board, will be participating as part of a regulatory panel (the “Panel”) at the 2022 IPA World Congress and Probiota Americas Event (“Probiota Americas” or the “Event”).
Wellbeing Digital Sciences’ Dr. Corey Hilmas Invited to Participate as a Regulatory Panelist at Probiota Americas Event
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
